Nektar Therapeutics (NKTR) Total assets 2016–2025
Nektar Therapeutics (NKTR) total assets at each fiscal year-end, per SEC filings.
$280.4MFY2025 · since FY2016: $568.9M → $280.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $280.4M | -7.7% |
| FY2024 | $303.9M | -23.7% |
| FY2023 | $398.0M | -44.0% |
| FY2022 | $710.6M | -36.4% |
| FY2021 | $1.1B | -27.4% |
| FY2020 | $1.5B | -22.2% |
| FY2019 | $2.0B | -8.0% |
| FY2018 | $2.2B | +322.5% |
| FY2017 | $508.9M | -10.5% |
| FY2016 | $568.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NKTR financial trends
NKTR RevenueNKTR Net incomeNKTR Net marginNKTR Gross profitNKTR Gross marginNKTR Operating incomeNKTR Operating marginNKTR Operating cash flowNKTR Free cash flowNKTR Capital expendituresNKTR Return on equityNKTR Stock buybacksNKTR Dividends paidNKTR Total liabilitiesNKTR Shareholders’ equityNKTR overview →